Andrew Lawrence’s team has made a crucial discovery about the molecular mechanism of relapsing addiction, which might help fight the scourge of drug addiction. [ + ]

Animal models can reveal how addicts respond to environmental cues, triggering relapse. [ + ]

Florey Neuroscience Institutes’ Professor Andrew Lawrence is hot on the trail of treatments for addiction. [ + ]

QRxPharma (ASX:QRX) will meet with the FDA for a pre-NDA meeting following positive results from pivotal phase III trial of MoxDuo. [ + ]

The Chief Scientist for Australia, Professor Penny Sackett, has resigned.

Australia's Chief Scientist, Professor Penny Sackett, has stunned the scientific community with her sudden resignation today. [ + ]

Nominations are now open for the prestigious Prime Minister's Prizes for Science. [ + ]

CSIRO joins the global battle against bird flu and other mutating viruses.

Acquisitions are commonplace in the IT industry. ARN investigates what makes the difference between a successful acquisition or merger, and where things can (and do) go wrong. [ + ]

IRL informed the Education and Science Select Committee that the future of the company is bright, provided it maintains its current momentum.

A free GC Column Selector app for the iPhone has been released by Thermo Fisher Scientific.

Senate’s gene patenting report fails to offer solutions to Australian healthcare industry.

bioMD is looking to acquire Allied Medical, which also owns Coridon, led by Ian Frazer, to produce a new diversified healthcare company. [ + ]

CSIRO may be able to control the spread of bat-borne diseases after discovering they can host deadly viruses without ill-effects.

Alexion Pharmaceuticals has acquired patents and assets from German company, Orphatec Pharmaceuticals, for a therapy to treat molybdenum cofactor deficiency (MoCD) Type A. [ + ]